Diabetes

President Trump announced the plan today at the White House, accompanied by insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, as well as AHIP and major health plans.

In the first report of its kind, researchers examined the combined effect of liraglutide and propranolol on the hearts of patients with both type 2 diabetes and cirrhosis.

The presentation at Virtual ISPOR 2020 found that 7% of a group of Medicare beneficiaries with type 2 diabetes was experiencing food insecurity, a rate the lead author found "alarming."

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Research shows a strong and consistent association between pregnancy loss and type 2 diabetes (T2D), and the risk of developing T2D increases with a higher number of pregnancy losses, according to a study published in Diabetologia.

Reduced physical activity and greater nightly variation in sleep duration are associated with less favorable metabolic profiles in adolescents, including higher fat accumulation and higher insulin levels, according to a study published in PLoS One.

Teenagers with obesity, type 2 diabetes (T2D), or high blood pressure may have a higher risk of experiencing premature vascular aging compared with teens without the conditions, according to a study published in the Journal of the American Heart Association.

In a first-quarter earnings report, Novo Nordisk announced promising initial data from a phase 2 trial testing the efficacy of glucagon-like peptide-1 agonist semaglutide (Ozempic) in individuals with nonalcoholic steatohepatitis (NASH).

Investigators found no statistically significant evidence associating rotavirus vaccinations with type 1 diabetes (T1D) in children, according to results from a large cohort study published in JAMA Pediatrics.

African Americans with severe sleep apnea are more likely to have higher blood glucose levels, according to a new study published in the Journal of the American Heart Association. High blood glucose levels increase the risk of developing diabetes, a disease already more prevalent in African Americans.

Widespread testing targeted at the most vulnerable communities at risk of suffering complications from the coronavirus disease 2019 (COVID-19) is imperative to successfully managing this pandemic, said Tracey Brown, chief executive officer of the American Diabetes Association.

Women with lower ovarian reserve—defined as the number and quality of a woman’s eggs—are not at increased risk for obesity and diabetes, according to a study published in Menopause.

Individuals with type 2 diabetes (T2D) who underwent Roux-en-Y gastric bypass exhibited greater weight loss, a slightly higher T2D remission rate, less T2D relapse, and better long-term glycemic control compared with those who had sleeve gastrectomy, according to a study published in JAMA Surgery.

Obesity increases the risk of developing type 2 diabetes (T2D) regardless of genetic predisposition to the disease, according to a study published in Diabetologia. These findings emphasize that having a normal body weight is crucial to prevent T2D.

Recently, it has been shown that the mechanism by which glucose is managed can have a substantial impact on cardiovascular outcomes. For this reason, along with increasing prevalence of type 2 diabetes (T2D), effective, patient-centered management of coronary artery disease (CAD) in patients with diabetes is imperative to optimize patient outcomes, the American Heart Association said.

Women born by cesarean section were 11% more likely to be obese and had a 46% higher chance of developing type 2 diabetes (T2D) compared with women born by vaginal delivery, according to a study published in JAMA Network Open.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Centivo has launched a new health plan solution, aimed at lowering costs for employees; trial results show dead bacteria may be effective in treating IBS; continuous glucose monitoring systems are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19).

Good dental hygiene is associated with a decreased risk of developing diabetes, according to study results published in Diabetologia, the journal of the European Association for the Study of Diabetes.

Researchers created a machine-learning–based model to help predict which patients will develop diabetes, according to an abstract to be published in the Journal of the Endocrine Society.

This week, the top managed care news includes a CDC report says diabetes is the condition most linked with coronavirus disease 2019, CMS temporarily suspends rules to give hospitals more capacity during the COVID-19 pandemic, and a late-stage trial for dapagliflozin ends early after showing efficacy for chronic kidney disease.

Vitamin D deficiency in women with gestational diabetes mellitus (GDM) is associated with an elevated risk of postpartum glucose intolerance, according to a study published in Endocrinology and Metabolism.

In the United States, diabetes mellitus is the most frequently reported condition among the 7162 coronavirus disease 2019 (COVID-19) cases for whom comorbidity data is available, according to new CDC information.

Elevated glucose levels are common in solid-organ transplant recipients and associated with short- and long-term mortality risks in hospitalized transplant recipients. This increased mortality risk was independent of age, gender, smoking, alcohol, or comorbidities.

According to the CDC, individuals with diabetes may experience more serious complications from the novel coronavirus (COVID-19) than the general population.

Researchers found that 1 in 10 patients with diabetes initially hospitalized for treatment of common medical conditions was discharged with intensified diabetes medications, with nearly half unlikely to benefit due to limited life expectancy or already having an optimal blood glucose level.

Diabetes pay-for-performance programs may reduce all-cause mortality in patients with type 2 diabetes (T2D).

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.